Genetic Testing by Age at Onset in Parkinson Disease
This cohort study evaluates the association between age at onset and family history of Parkinson disease in patients who carry pathogenic variants.
Authors
- Ana Westenberger (ORCID: https://orcid.org/0000-0001-8062-6959)
- James C. Beck (ORCID: https://orcid.org/0000-0002-4884-9893)
- Christine Klein (ORCID: https://orcid.org/0000-0003-2102-3431)
- Kamalini Ghosh Galvelis (ORCID: https://orcid.org/0009-0000-4178-0777)
- Meike Kasten (ORCID: https://orcid.org/0000-0003-1910-6035)
- IR König
- Norbert Brüggemann
- Katja Lohmann
- Eva-Juliane Vollstedt
- Peter Bauer
- Lara M. Lange
- Brit Mollenhauer
- Joanne Trinh
- Alexander Balck
- Claudia Trenkwalder
- For the Global Parkinson’s Genetics Program (GP2), the ROPAD Study Group, and the PDGENEration Study
- Roy N. Alcalay
Institutions
- National Institutes of Health (US)
- Tel Aviv University (IL)
- Columbia University Irving Medical Center (US)
- Tel Aviv Sourasky Medical Center (IL)
- Universitätsmedizin Göttingen (DE)
- Paracelsus Elena Klinik Kassel (DE)
- National Institute on Aging (US)
- Centogene (Germany) (DE)
- Parkinson's Foundation (US)
- University of Göttingen (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2026-05-11
- DOI
- https://doi.org/10.1001/jamaneurol.2026.1112
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00